Measurement of complement receptor 1 on neutrophils in bacterial and viral pneumonia

被引:16
作者
Hohenthal, U
Nuutila, J
Lilius, EM
Laitinen, I
Nikoskelainen, J
Kotilainen, P
机构
[1] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland
[2] Univ Turku, Dept Biochem, SF-20500 Turku, Finland
关键词
D O I
10.1186/1471-2334-6-11
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Background: A reliable prediction of the causative agent of community-acquired pneumonia (CAP) is not possible based on clinical features. Our aim was to test, whether the measurement of the expression of complement receptors or Fc gamma receptors on neutrophils and monocytes would be a useful preliminary test to differentiate between bacterial and viral pneumonia. Methods: Sixty-eight patients with CAP were studied prospectively. Thirteen patients had pneumococcal pneumonia; 13 patients, influenza A pneumonia; 5 patients, atypical pneumonia, and 37 patients, aetiologically undefined pneumonia. Leukocyte receptor expression was measured within 2 days of hospital admission. Results: The mean expression of complement receptor 1 (CR1) on neutrophils was significantly higher in the patients with pneumococcal pneumonia than in those with influenza A pneumonia. The mean expression of CR1 was also significantly higher in aetiologically undefined pneumonia than in influenza A pneumonia, but there was no difference between pneumococcal and undefined pneumonia. Conclusion: Our results suggest that the expression of CR1 is higher in classical bacterial pneumonia than in viral pneumonia. Determination of the expression of CR1 may be of value as an additional rapid tool in the aetiological diagnosis, bacterial or viral infection, of CAP. These results are preliminary and more research is needed to assess the utility of this new method in the diagnostics of pneumonia.
引用
收藏
页数:5
相关论文
共 17 条
[1]
Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia [J].
Almirall, J ;
Bolíbar, I ;
Toran, P ;
Pera, G ;
Boquet, X ;
Balanzó, X ;
Sauca, G .
CHEST, 2004, 125 (04) :1335-1342
[2]
ARSTILA PP, 1988, LAB DIAGNOSIS INFECT, P60
[3]
Community-acquired pneumonia [J].
File, TM .
LANCET, 2003, 362 (9400) :1991-2001
[4]
Grönlund MM, 1999, CLIN EXP IMMUNOL, V116, P521
[5]
Procalcitonin and C-reactive protein levels in community-acquired pneumonia: Correlation with etiology and prognosis [J].
Hedlund, J ;
Hansson, LO .
INFECTION, 2000, 28 (02) :68-73
[6]
Bronchoalveolar lavage in immunocompromised patients with haematological malignancy -: value of new microbiological methods [J].
Hohenthal, U ;
Itälä, M ;
Salonen, J ;
Sipilä, J ;
Rantakokko-Jalava, K ;
Meurman, O ;
Nikoskelainen, J ;
Vainionpää, R ;
Kotilainen, P .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (03) :203-211
[7]
Diagnostic value of bronchoalveolar lavage in community-acquired pneumonia in a routine setting:: A study on patients treated in a Finnish University Hospital [J].
Hohenthal, U ;
Sipilä, J ;
Vainionpää, R ;
Meurman, O ;
Rantakokko-Jalava, K ;
Nikoskelainen, J ;
Kotilainen, P .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (03) :198-203
[8]
Early impairment of coronary flow reserve is not associated with Chlamydia pueumoniae antibodies [J].
Janatuinen, T ;
Friberg, J ;
Viljanen, MK ;
Raitakari, OT ;
Nuutila, P ;
Vainionpää, R ;
Oksi, J ;
Peltonen, R ;
Engblom, E ;
Laine, H ;
Knuuti, J .
ANNALS OF MEDICINE, 2002, 34 (04) :284-290
[9]
INFLUENZA-A AND INFLUENZA-B VIRUS IGG AND IGM SEROLOGY BY ENZYME IMMUNOASSAYS [J].
KOSKINEN, P ;
VUORINEN, T ;
MEURMAN, O .
EPIDEMIOLOGY AND INFECTION, 1987, 99 (01) :55-64
[10]
COMMUNITY-ACQUIRED PNEUMONIA [J].
MARRIE, TJ .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (04) :501-515